Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity

Fig. 1

Empagliflozin attenuated the atherosclerotic lesion area. Schematic protocol for mice treatments (a). Representative macroscopic image (b), En face Oil Red O staining (c) and quantitative results (d), HE staining (e), Movat staining (f) and quantitative results (g). n = 6, ** P<0.01, ***P<0.001. AS, atherosclerosis group; EMPA, empagliflozin group. One-way analysis of variance with the Bonferroni post hoc test was used. The black arrow indicated the atherosclerotic lesion on aortic arch in b & c, and on aortic root in e & f

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X